Senate hearing set for Trump FDA pick embraced by anti-abortion

Another confirmation hearing, another nominee the left has already decided is a walking crisis. Dr. Heidi Overton gets her Senate grilling Thursday, and you can guess the game plan. She’s a former White House health policy adviser with a record of questioning FDA orthodoxy. For that, she’ll be treated like a threat to public health itself. The funny part is that the loudest objections revolve around her pro-life views, as if personal conviction disqualifies a person from ensuring your medicine isn’t killing you.

We’d rather the senators ask about the actual job. Drug approvals, food reform, vaccine oversight, the agency’s embarrassing surrender to its own bureaucracy. Those are the files that matter. Overton has spent years inside those arguments, not just as a critic but as someone who understands how the FDA’s incentives get twisted. The anti-abortion label is a distraction, and it’s a telling one. The left isn’t afraid she’ll mishandle a flu season. They’re afraid she’ll blow up the cozy relationship between regulators and the industry they’re supposed to police.

What concerns them is that she might take a skeptical eye to mandates and expedited approvals that go south. That she might ask why a vaccine or a drug gets fast-tracked while safer, cheaper alternatives sit in limbo. That’s the real heresy in Washington. If she’s hostile to abortion, fine, she’s said so. But the FDA doesn’t perform abortions. The FDA approves products and sets safety standards. The people attacking her are the same ones who trust federal agencies with their children’s health, then get shocked when those agencies tell them to just trust the process.

We’ll be watching Thursday. Not for the pearl-clutching questions about “reproductive rights,” but for whether the committee lets her talk about the actual mission. Do your job, Dr. Overton. Root out the captured regulators, push back on the food industry’s nonsense, and treat Americans like grown-ups instead of subjects. If that makes her a radical, then maybe the FDA needed a radical all along.